refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: a case report

Clicks: 122
ID: 238151
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #15 of 15 articles by views in urology annals

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
A 40-year-old male developed refractory acute promyelocytic leukemia (APL) after various treatments including all-trans retinoic acid, tamibarotene, arsenic trioxide (As2O3), conventional chemotherapy, and autologous peripheral blood stem cell transplantation. We attempted to use both tamibarotene and As2O3 as a combination therapy, and he achieved molecular complete remission. Grade 2 prolongation of the QTc interval on the electrocardiogram was observed during the therapy. The combination therapy of As2O3 and tamibarotene may be effective and tolerable for treating refractory APL cases who have no treatment options, even when they have previously been treated with tamibarotene and As2O3 as a single agent.
Reference Key
kojima2016leukemiarefractory Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Minoru Kojima;Daisuke Ogiya;Akifumi Ichiki;Ryujiro Hara;Jun Amaki;Hidetsugu Kawai;Hiroki Numata;Ai Sato;Mitsuki Miyamoto;Rikio Suzuki;Shinichiro Machida;Hiromichi Matsushita;Yoshiaki Ogawa;Hiroshi Kawada;Kiyoshi Ando
Journal urology annals
Year 2016
DOI
10.1016/j.lrr.2016.01.001
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.